Serum albumin, NLR and PLR in pre-treatment assessment of bronchiectasis exacerbations.

Bronchiectasis severity scores, through useful in disease progression, are inadequate for monitoring exacerbation treatment. Therefore, it is of interest to investigate the correlation between serum albumin, Platelet Lymphocyte Ratio (PLR) and Neutrophil Lymphocyte Ratio (NLR) with disease severity in exacerbated bronchiectasis patients. Serum albumin and NLR demonstrated significant correlation with disease severity, while PLR did not. Post-treatment, both markers showed improvement, indicating their role in treatment monitoring. Thus, we show NLR and serum albumin as reliable biomarkers for assessing severity and monitoring treatment response in bronchiectasis.